Latin America Next Generation Sequencing Market Size, Share & Trends 2025


Posted January 27, 2026 by ved_fma07

The Latin American next-generation sequencing (NGS) market is on an exciting upward trajectory, fueled by a combination of dynamic factors.

 
Latin America Next Generation Sequencing Market By Type, By Sequencing Type, By Technology, By Application, By End user and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis Historical Data from 2018-2024 and Forecast 2025-2033
According to FutureWise analysis, the Latin America next-generation sequencing market in 2025 is US$0.44 billion, and is expected to reach US$1.49 billion by 2033 at a CAGR of 16.47%.
The Latin American next-generation sequencing (NGS) market is on an exciting upward trajectory, fueled by a combination of dynamic factors. This impressive growth mirrors the region's swiftly evolving genomics research landscape, bolstered by increased government funding for precision medicine initiatives and a rising awareness of the transformative potential of NGS in clinical diagnostics, oncology, and infectious disease management. At the forefront of this movement are Brazil and Mexico, which are reaping the rewards of their relatively advanced healthcare systems and well-established research institutions. Both countries are actively working to weave genomic medicine into their national healthcare strategies. As sequencing technology becomes more affordable and bioinformatics expertise becomes more widely accessible, academic institutions, hospitals, and private labs across the region are embracing NGS like never before. The urgency of the situation is underscored by the rising rates of cancer, the growing prevalence of genetic disorders, and the imperative for enhanced pathogen surveillance—challenges starkly highlighted by the recent COVID-19 pandemic. These factors are propelling the clinical adoption of NGS-based diagnostic solutions into the spotlight. However, the journey isn't without its hurdles. Limited reimbursement policies, regulatory complexities, and infrastructural disparities in some countries could pose obstacles to growth. Yet, hope is on the horizon! Collaborations between international sequencing companies and local institutions are actively breaking down these barriers, thereby broadening market access and paving the way for a brighter future in genomic medicine across the region.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Latin America Next Generation Sequencing Market trends that shall affect the overall market growth.

Request a Free Sample @
https://www.futurewiseresearch.com/contact.aspx?rpt=10200&type=requestsample

By Type
• Consumables
o Sample Preparation Consumables
o DNA Fragmentation and Amplification
o Library Preparation and Target Enrichment
o Quality Control
o Other Consumables
• NGS Platforms/Instruments
o Illumina NGS Platforms/Instruments
o Thermo Fisher Scientific NGS Platforms/Instruments
o Pacific Biosciences NGS Platforms/Instruments
o Oxford Nanopore NGS Platforms/Instruments
o Others
• Software
• Services

By Sequencing Type
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing
• Others

By Technology
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Sequencing by Ligation
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing
• Others

By Application
• Clinical Application
o Oncology
o Reproductive Health Diagnostics
o Non-Invasive Pre-natal Testing
o Carrier Screening
o In-Vitro fertilization
o Newborn Screening
o Cardiovascular
o Others
• Research Application
o Drug Discovery
o Agriculture and Animal Research
o Others

By End user
• Clinical Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Others

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Latin America Next Generation Sequencing Market:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Pacific Biosciences of California, Inc.
• Qiagen N.V.
• Oxford Nanopore Technologies Ltd
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• PerkinElmer, Inc.
• F. Hoffmann-La Roche AG
• 10x Genomics, Inc..
• Macrogen Inc.
• Partek Inc.
• Agilent Technologies Inc.
• Genomatix Software GmbH
• GATC Biotech Ag

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10200&license=multi

**Objectives of this Study: **
1. To provide a comprehensive analysis of the Latin America Next Generation Sequencing Market By Type, By Sequencing Type, By Technology, By Application, By End user and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse Content Requests
Contact Email [email protected]
Issued By FutureWise Research
Country United States
Categories Health
Tags latin america next generation sequencing market scale , latin america next generation sequencing market scope , latin america next generation sequencing market share
Last Updated January 27, 2026